|
|
|
Beneficial effect of arginine vasopressin on
hemorrhagic shock through improving the vascular reactivity |
| LI Tao, YANG Guangming, XU Jing, LIU Jiancang, LIU Liangming |
| State Key Laboratory of Trauma, Burns and Combined Injury, the 2nd Department of Research Institute of Surgery, Daping Hospital, Third Military Medical University |
|
|
|
|
Abstract The vascular reactivity and calcium sensitivity were decreased following hemorrhagic shock. Arginine vasopressin (AVP) was beneficial to endotoxic, infectious/septic and hemorrhagic shock. Our previous studies found that Rho kinase played an important role in the occurrence of calcium desensitization following shock. It was reported that AVP was with stimulation effect of Rho kinase. So we hypothesized that AVP might have beneficial effect on shock via activation of Rho kinase to regulate the calcium sensitivity and vascular reactivity. Hemorrhagic shock (40 mmHg for 2 h) Wistar rats in vivo were adopted to observe the effects of small dose of AVP on hemodynamics, 24-h survival rate, the pressor effect of norepinephrine (NE) and the contractility of superior mesenteric artery (SMA). Isolated SMAs from hemorrhagic shock rats were adopted to observe the effects of AVP on vascular reactivity and calcium sensitivity and its relationship to Rho kinase with an isolated organ perfusion system. The results show that AVP at the concentration of 0.1 U/kg and 0.4 U/kg significantly improved the hemodynamic parameters and the 24-h survival rate of hemorrhagic shock rats. Meanwhile, these dosages of AVP significantly increased the pressor effect of NE and the contractile response of SMA to NE. Y-27632 (3 ?g/kg), a Rho kinase specific inhibitor, abolished the beneficial effects of AVP. In vitro, the calcium sensitivity and vascular reactivity of SMA to calcium and NE were significantly decreased following hemorrhagic shock. AVP at the concentration of 0.5 nmol/L and 5 nmol/L significantly increased the calcium sensitivity and vascular reactivity. These effects of AVP were abolished by Y-27632 (10 ?mol/L). Taken together, the results suggest that AVP at 0.1 U/kg and 0.4 U/kg is beneficial to hemorrhagic shock by improving the vascular reactivity, which involves activation of Rho kinase.
|
|
Issue Date: 05 September 2008
|
|
| 1 |
Oliver G . Onthe physiological of extracts of the pituitary and certain other glandularorgans. J Physiol, 1985, 18(3): 27–33
|
| 2 |
Albert M, Losser M R, Hayon D . Systemic and renal macro- and microcirculatory responsesto arginine vasopressin in endotoxic rabbits. Crit Care Med, 2004, 32(9): 1891–1898.
doi:10.1097/01.CCM.0000139708.10718.E3
|
| 3 |
Dunser M W, Mayr A J, Ulmer H . Arginine vasopressin in advanced vasodilatory shock:a prospective, randomized, controlled study. Circulation, 2003, 107(18): 2313–2319.
doi:10.1161/01.CIR.0000066692.71008.BB
|
| 4 |
Dunser M W, Wenzel V, Mayr A J . Management of vasodilatory shock: defining the role ofarginine vasopressin. Drugs, 2003, 63(3): 237–256.
doi:10.2165/00003495‐200363030‐00001
|
| 5 |
Raedler C, Voelckel W G, Wenzel V . Treatment of uncontrolled hemorrhagic shock after livertrauma: fatal effects of fluid resuscitation versus improved outcomeafter vasopressin. Anesth Analg, 2004, 98(6): 1759–1766.
doi:10.1213/01.ANE.0000117150.29361.5A
|
| 6 |
Stadlbauer K H, Wagner Berger H G, Raedler C . Vasopressin, but not fluid resuscitation, enhances survivalin a liver trauma model with uncontrolled and otherwise lethal hemorrhagicshock in pigs. Anesthesiol, 2003, 98(3): 699–704.
doi:10.1097/00000542‐200303000‐00018
|
| 7 |
Voelckel W G, Raedler C, Wenzel V . Arginine vasopressin, but not epinephrine, improves survivalin uncontrolled hemorrhagic shock after liver trauma in pigs. Crit Care Med, 2003, 31(4): 1160–1165.
doi:10.1097/01.CCM.0000060014.75282.69
|
| 8 |
Uehahato M, Ishizaki T, Satoh H . Calcium sensitization of smooth muscle mediated by aRho-associated protein kinase in hypertension. Nature, 1997, 389(6654): 990–994.
doi:10.1038/40187
|
| 9 |
Xu J, Liu L M . The role of calcium desensitizationin vascular hyporeactivity and its regulation following hemorrhagicshock. Shock, 2005, 23(6): 576–581
|
| 10 |
Cavarape A, Bauer J, Bartoli E . Effects of angiotensin II, arginine vasopressin and tromboxaneA2 in renal vascular bed: role of rho-kinase. Nephrol Dial Transplant, 2003, 18(9): 1764–1769.
doi:10.1093/ndt/gfg291
|
| 11 |
Liu L M, Ward J A, Dubick M A . Hemorrhagic shock induced vascular hyporeactivity tonorepinephrine in select vasculatures of rats and the roles of nitricoxide and endothelin. Shock, 2003, 19(3): 208–214.
doi:10.1097/00024382‐200303000‐00003
|
| 12 |
Liu L M, Dubick M A . Regional diversity of hemorrhagicshock-induced vascular hyporeactivity and the roles of nitric oxideand endothelin: relationship to gene expression of NO/ET-1 and selectcytokines in corresponding organs. J SurgRes, 2005, 125(2): 128–136.
doi:10.1016/j.jss.2004.12.008
|
| 13 |
Zhao K S, Huang X L, Liu J . New approach to treatment of shock-restitution of vasoreactivity. Shock, 2002, 18(2): 189–192.
doi:10.1097/00024382‐200208000‐00017
|
| 14 |
Kai L, Wang Z F, Hu D Y . Opioid receptor antagonists modulate Ca2+-activated K+ channels in mesenteric arterialsmooth muscle cells of rats in hemorrhagic shock. Shock, 2003, 19(1): 85–90.
doi:10.1097/00024382‐200301000‐00016
|
| 15 |
Matsui T, Amano M, Yamamoto T . Rho-associated kinase, a novel serine/threonine kinase,as a putative target for small GTP binding protein Rho. EMBO J, 1996, 15(9): 2208–2216
|
| 16 |
Kimura K, Ito M, Amano M . Regulation of myosin phosphatase by Rho and Rho-associatedkinase (Rho-kinase). Science, 1996, 273(5272): 245–248.
doi:10.1126/science.273.5272.245
|
| 17 |
Li T, Liu L M, Xu J, Yang G M, Ming J . Changes of Rho kinase activity afterhemorrhagic shock and its role in shock-induced biphasic responseof vascular reactivity and calcium sensitivity. Shock, 2006, 26(5): 504–509.
doi:10.1097/01.shk.0000228796.41044.41
|
| 18 |
Fleisher S, Kagan E, Grossman N . Multiple effects of arginine vasopressin on prostaglandinE2 synthesis in fibroblasts. Eur J Pharmacol, 2004, 485(1–3): 53–59
|
| 19 |
Sirintorn Y, Ehab A A, Cheng Y Y . The role of arginine vasopressin in diabetes-associatedincrease in glucagons secretion. RegulatoryPeptides, 2004, 122(3): 157–162.
doi:10.1016/j.regpep.2004.06.010
|
| 20 |
Voelckel W G, Lurie K G, Lindner K H . Vasopressin improves survival after cardiac arrest inhypovolemic shock. Anesth Analg, 2000, 91(3): 627–634.
doi:10.1097/00000539‐200009000‐00024
|
| 21 |
Bauer J, Parekh N . Variation in cell signalingpathways for different vasoconstrictor agonists in renal circulationof rats. Kidney Int, 2003, 63(2): 2178–2183.
doi:10.1046/j.1523‐1755.2003.00021.x
|
| 22 |
Malay M B, Ashton R C Jr, Landdry D W . Low-dose vasopressin in the treatment of vasodilatoryseptic shock. J Trauma, 1999, 47(4): 699–703
|
| 23 |
Landry D W, Levin H R, Gallant E M . Vasopressin deficiency contributes to the vasodilatationof septic shock. Circulation, 1997, 95(5): 1122–1125
|
| 24 |
Kawano Y, Fukata Y, Oshiro N . Phosphorylation of myosin-binding subunit (MBS) of myosinphosphatase by Rho-kinase during cell migration and cytokinesis. J Cell Biol, 1999, 147(5): 1023–1038.
doi:10.1083/jcb.147.5.1023
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
